SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cheap Drugs at What Price to Innovation: Does the Compulsory Licensing of Pharmaceuticals Hurt Innovation
0 references·12 citing·44 second hop
Cheap Drugs at What Price to Innovation: Does the Compulsory Licensing of Pharmaceuticals Hurt Innovation (2003)Cheap Drugs at What Price to Innovation: …Do patent pledges accelerate innovation? (2023)Do patent pledges accelerate …The COVID‐19 pandemic and long‐term incentives for developing vaccines: Patent law under stress (2022)The COVID‐19 pandemic and lon…Compulsory licensing and innovation – Historical evidence from German patents after WWI (2017)Compulsory licensing and inno…Patent Laws and Innovation: Evidence from Economic History (2012)Patent Laws and Innovation: E…Inverse Enclosure: Abdicating the Green Technology Landscape (2012)Inverse Enclosure: Abdicating…Waiver Solution in Public Health and Pharmaceutical Domain Under TRIPS Agreement (2011)Waiver Solution in Public Hea…Investments in Pharmaceuticals Before and After TRIPS (2009)Investments in Pharmaceutical…Compulsory Licensing: Evidence from the Trading with the Enemy Act (2009)Compulsory Licensing: Evidenc…Compulsory Licensing in Canada and Thailand: Comparing Regimes to Ensure Legitimate Use of the WTO Rules (2009)Compulsory Licensing in Canad…Compulsory Licensing - Evidence from the Trading with the Enemy Act (2009)Compulsory Licensing - Eviden…A evolução do sistema internacional de propriedade intelectual: proteção patentária para o setor farmacêutico e acesso a medicamentos (2007)A evolução do sistema interna…Patents, Essential Medicines, and the Innovation Game (2003)Patents, Essential Medicines,…The WTO Medicines Decision: World Pharmaceutical Trade and the Protection of Public Health (2005)The International Enclosure Movement (2007)Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options (2009)Vaccine nationalism and equitable access to COVID-19 pharmaceuticals: TRIPS Agreement under trial (again) (2021)Determinants of patent rights: A cross-national study (1997)Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not) (2000)Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry (2004)Policy Complements to the Strengthening of IPRS in Developing Countries (2010)The Impact of Modularity on Intellectual Property and Value Appropriation (2011)The High Price of “Free” Trade: U.S. Trade Agreements and Access to Medicines (2013)The Economic Impact of the Patent System. (1975)Appropriating the Returns from Industrial Research and Development (1987)Challenges to Technology Transfer: A Literature Review of the Constraints on Environmental Technology Dissemination (2009)Scaling Up Chronic Disease Prevention Interventions in Lower- and Middle-Income Countries (2013)Compulsory licensing, price controls, and access to patented foreign products (2014)Sectoral patterns of technical change: Towards a taxonomy and a theory (1984)Sectoral Patterns of Technical Change : Towards a Taxonomy and a Theory : Research Policy (1987)Integrating public health concerns into patent legislation in developing countries (2000)Gestão de ativos de Propriedade Intelectual: um estudo sobre as práticas da Braskem S.A. (2013)Academic patenting in Brazil: the role of academic inventors in PCT patent applications – 2002-2012 (2017)Saúde global e política externa brasileira: negociações referentes à inovação e propriedade intelectual (2017)The Economic Implications of Learning by Doing (1962)Schooling and Labor Market Consequences of School Construction in Indonesia: Evidence from an Unusual Policy Experiment (2001)The NBER Patent Citation Data File: Lessons, Insights and Methodological Tools (2001)Did Plant Patents Create the American Rose? (2011)Patent Citations - An Analysis of Quality Differences and Citing Practices in Hybrid Corn (2011)The effects of national environmental information disclosure program on the upgradation of regional industrial structure: Evidence from 286 prefecture-level cities in China (2021)Economic Welfare and the Allocation of Resources for Invention (1962)Capitalism, Socialism and Democracy (1997)The Theory of Economic Development (2003)Absorptive capacity, cluster linkages, and innovation (2017)Patent protection in developing countries and global welfare: WTO obligations versus flexibilities (2019)The Consequences of Radical Patent-Regime Change (2020)The Tragedy of the Anticommons: Property in the Transition from Marx to Markets (1998)Navigating the Patent Thicket: Cross Licenses, Patent Pools, and Standard Setting (2000)Understanding the process of economic change (2005)University Versus Corporate Patents: A Window On The Basicness Of Invention (1997)Did Unilateral Divorce Laws Raise Divorce Rates? A Reconciliation and New Results (2006)Are intellectual property rights working for society? (2023)Pledge to green: the green innovation effect of intellectual property pledge financing pilot policy (2024)The Impact of green finance reform on firms' patent quality: An empirical study from Chinese listed manufacturing firms (2025)Shedding Light on Inventors' Returns to Patents (2015)The Surprising Resilience of the Patent System (2016)THE DANCE OF THE DYNAMICS: THE INTERPLAY OF TRADE AND GROWTH (2018)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2009Investments in Pharmaceuticals Before and After TRIPS113 cited
  • 2009Compulsory Licensing in Canada and Thailand: Comparing Regimes to Ensure Legitimate Use of the WTO Rules70 cited
  • 2023Do patent pledges accelerate innovation?56 cited
  • 2007A evolução do sistema internacional de propriedade intelectual: proteção patentária para o setor farmacêutico e acesso a medicamentos51 cited
  • 2017Compulsory licensing and innovation – Historical evidence from German patents after WWI30 cited
  • 2009Compulsory Licensing: Evidence from the Trading with the Enemy Act24 cited
  • 2012Patent Laws and Innovation: Evidence from Economic History21 cited
  • 2003Patents, Essential Medicines, and the Innovation Game10 cited
  • 2022The COVID‐19 pandemic and long‐term incentives for developing vaccines: Patent law under stress10 cited
  • 2011Waiver Solution in Public Health and Pharmaceutical Domain Under TRIPS Agreement10 cited
  • 2009Compulsory Licensing - Evidence from the Trading with the Enemy Act9 cited
  • 2012Inverse Enclosure: Abdicating the Green Technology Landscape6 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work